Skip to main content
Smart Investors Daily
SK

NYSE · SKHHY

Sonic Healthcare Limited

Healthcare · Medical - Diagnostics & Research

$13.30

Up+$0.09 (+0.68%)

Updated Oct 27, 2026, 6:18 AM

SID Score

5.8/10

Composite research score

Smart Money

46/100

Neutral

Market cap
7.41B
P/E ratio
21.76
Dividend yield
5.12%
52-week range
— – —
Volume
19.03K
Avg. volume
220.32K

Price performance · SKHHY

SKHHY price history

1M range · 0 trading sessions · Daily adjusted prices

SKHHY does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest SKHHY news

The latest Smart Investors Daily articles mentioning SKHHY.

SKHHY research

Overview

Company profile and research snapshot.

Company profile

SONIC HEALTHCARE SP/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Hold
Average target
$30.15
Implied upside
—
Analysts
18
SKHHY recent ratings
DateFirmRatingTarget
Sep 22, 2026BELL POTTER SECURITIESBuy—
Sep 2, 2026JEFFERIESHold—
Aug 21, 2026MACQUARIE RESEARCHNeutral—
Aug 20, 2026E&PNeutral—
Jul 2, 2026BELL POTTER SECURITIESBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 16, 2026

Sonic Healthcare (ASX:SHL) Shares May Trade At A Discount On Earnings

Sonic Healthcare has seen its share price fall over several time frames, and that slump puts fresh focus on a simple question for investors. Are you now paying a price that is properly explained by what the company earns today and what those earnings can realistically support? Over the past 5 years the stock has declined 43.1%, which makes the current share price far more about what the earnings profile looks like now than about past gains. The business relies on converting medical testing...

Yahoo · Sep 4, 2026

Clinical Laboratory Services Market Size, Share & Trends Analysis - Global Opportunity Analysis & Industry Forecast (2026-2036)

The global clinical laboratory services market was valued at USD 274.6 billion in 2025 and is forecast to reach USD 468.2 billion by 2036, rising from USD 298.4 billion in 2026 at a 4.6% CAGR. Growth is driven by chronic diseases, preventive healthcare, molecular diagnostics, genomic testing, precision medicine, laboratory automation, AI-enabled diagnostics, and at-home testing. North America leads, while Asia-Pacific is set for the fastest growth. The report analyzes key segments, regions, oppo

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.